Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS

Shuna Luo,1 Xiaofei Xu,1 Xingnong Ye,1,2 Xiaoqiong Zhu,1 Cai Wu,1 Dan Chen,1 Jingxia Jin,1 Yan Zheng,1 Mengli Zheng,1 Jian Huang1,2 1Department of Hematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, People’s Republic of China; 2Department o...

Full description

Bibliographic Details
Main Authors: Luo S, Xu X, Ye X, Zhu X, Wu C, Chen D, Jin J, Zheng Y, Zheng M, Huang J
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/ruxolitinib-plus-decitabine-effectively-treats-myelodysplastic-syndrom-peer-reviewed-article-OTT